PAX2 and renal carcinoma: Furthermore, it was confirmed that this approach increases apoptosis and sensitizes renal cancer cells to other chemotherapeutic drugs, suggesting that PAX2 can be an excellent target for therapeutic intervention in renal disease [63,64,65].